Detalhe da pesquisa
1.
Pathological complete remission of relapsed tumor by photo-activating antibody-mimetic drug conjugate treatment.
Cancer Sci
; 113(12): 4350-4362, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36121618
2.
Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.
Protein Expr Purif
; 192: 106043, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34973460
3.
1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrest.
J Pharmacol Exp Ther
; 332(3): 795-802, 2010 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19955487
4.
siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines.
Photochem Photobiol
; 85(4): 1020-7, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19320847